GEN-1184 is under clinical development by Genmab and currently in Phase II for Epithelial Ovarian Cancer. According to GlobalData, Phase II drugs for Epithelial Ovarian Cancer have a 38% phase ...
Announcing a new publication for Acta Materia Medica journal. Fatty acid (FA) reprogramming has a significant role in liver cancer. However, the contribution of FA metabolism reprogramming to the ...
INR:7616. bet365 free bet Yang Luhan co-founded a company that is expected to transplant pig organs into humans and received $125 million in funding Study finds n ...